David Shaw

A technology showcase

As quantum hardware advances, the distinction between Noisy Intermediate-Scale Quantum (NISQ) systems and fault-tolerant quantum computing is becoming a central focus in the race to develop scalable quantum technologies. This panel will bring together the leaders driving these developments to  explore the challenges and breakthroughs in qubit development and the journey from NISQ systems to fully fault-tolerant quantum computers. 

Key topics to be addressed by these industry leaders include: 

• What are the key differences between NISQ-era quantum systems and fault-tolerant quantum computing? 
• How are researchers and industry working to increase qubit counts while improving qubit quality and coherence times? 
• What are the practical challenges in scaling quantum hardware, and how do error correction and fault tolerance play a role in this progression? 
• What are the real-world applications for NISQ systems, and how far are we from transitioning to fault-tolerant quantum machines capable of solving larger, more complex problems? 
• How are industry and academia addressing the current limitations in qubit development, and what advancements can we expect in the near future for more robust quantum hardware? 

This session will provide insights into the evolving landscape of quantum hardware, the ongoing efforts to scale qubits, and the future potential of fault-tolerant quantum computing. 

Quantum computing has the potential to revolutionize the pharmaceutical and life sciences industries by solving complex problems that are currently beyond the reach of classical computers. This panel will explore how quantum technology is being applied to accelerate drug discovery, optimize molecular modeling, and enhance personalized medicine, among other innovations. 

Key topics include: 

• How is quantum computing being utilized in drug discovery, and what breakthroughs can it enable in the search for new therapies and treatments? 
• In what ways can quantum computing enhance molecular modeling and simulations, allowing for more accurate predictions of drug interactions and protein folding? 
• What role could quantum algorithms play in advancing genomics and personalized medicine, enabling more precise and efficient healthcare solutions? 
• What are the current limitations of quantum computing in pharma and life sciences, and how can companies and researchers prepare for the future integration of this technology? 
• How are pharmaceutical companies, research institutions, and quantum technology providers collaborating to advance quantum applications in life sciences? 

This panel will provide a deep dive into the opportunities and challenges that quantum computing presents for the pharma and life sciences sectors, highlighting its potential to drive the next wave of innovation in healthcare and medicine. 

Exploring the drivers for continuing sovereign engagement in quantum. How do governments see the opportunity and what levers they are seeking to pull. What is the size of the prize? 

Quantum computing is poised to revolutionize various industries, and Fortune 500 organizations are at the forefront of exploring its transformative potential. This panel will delve into how quantum technologies are reshaping business operations, driving innovation, and creating competitive advantages for these leading companies. 

Key discussion points include: 

How are Fortune 500 organizations currently leveraging quantum computing? 

Explore specific use cases and applications where quantum technologies are being integrated into business processes, from supply chain optimization to advanced data analytics. 

What are the competitive advantages gained through early adoption of quantum technologies? 

Discuss how organizations that embrace quantum computing are positioning themselves ahead of competitors and reimagining their approach to problem-solving. 

What challenges are Fortune 500 companies facing in implementing quantum solutions? 

Identify the barriers to adoption, including talent shortages, infrastructure requirements, and integration with existing systems. 

How is quantum computing influencing strategic decision-making and innovation within these organizations? 

Examine the role of quantum technologies in enhancing R&D efforts, driving product development, and informing business strategies. 

What collaborations and partnerships are Fortune 500 companies pursuing in the quantum space? 

Highlight how industry leaders are working with academia, startups, and technology providers to accelerate quantum research and application. 

What is the future outlook for quantum computing in Fortune 500 organizations? 

Discuss emerging trends, anticipated advancements, and the long-term implications of quantum technologies for these companies and their industries. 

This panel will feature executives and thought leaders from Fortune 500 organizations, providing valuable insights into the current and future impact of quantum computing on their businesses. Join us for an engaging discussion on how quantum technologies are shaping the landscape for the world's leading companies.